Cover Image: Local cutaneous refractoriness to sun exposure following omalizumab injections in solar urticaria

Br J Dermatol. 2023 Apr 20;188(5):e34. doi: 10.1093/bjd/ljad012.
No abstract available

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Chronic Disease
  • Humans
  • Omalizumab / adverse effects
  • Skin
  • Sunlight / adverse effects
  • Urticaria* / drug therapy
  • Urticaria* / etiology
  • Urticaria, Solar

Substances

  • Omalizumab
  • Anti-Allergic Agents